当前位置：首页 > 文献互助 > 互助详情

A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals复制

用户__dVOd073hsc 5小时前 19 10 待确认 帖子自动结束时间: 2025-05-11 08:13:13

1. 请及时下载文件确认是否正确, 系统将在 2025-05-13 11:37:29 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1126/science.adq1405复制

文献链接: https://www.science.org/doi/10.1126/science.adq1405复制

其他信息:

上一篇：Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

下一篇：Schiff-base crosslinked gelatin-mycosporine-like amino acids/dialdehyde starch composite film: a UV-resistant, biodegradable food packaging material

互助时间线

2025-05-06 11:37:29 [上传文件]

jodie0105上传了文件(zip 90.37 MB), 求助状态变成 待确认

2025-05-06 08:13:13 [发起求助]

最新发布的求助

A deconstruction–reconstruction strategy for pyrimidine diversification 2分钟前
Sotatercept: First Approval 6分钟前
A deconstruction–reconstruction strategy for pyrimidine diversification 7分钟前
A deconstruction–reconstruction strategy for pyrimidine diversification 27分钟前
Daily ingestion of Akkermansia mucciniphila for one month promotes healthy aging and increases lifespan in old female mice 58分钟前
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338) 1小时前
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. 1小时前
PerC B‐Cells Activation via Thermogenetics‐Based CXCL12 Generator for Intraperitoneal Immunity Against Metastatic Disseminated Tumor Cells 3小时前
Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers 3小时前
Repeated Temperature Fluctuation Exposure Causes Prolonged Skin Barrier Dysfunction 3小时前
… 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group 3小时前
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com